Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
Refractory soft tissue sarcomas carry a poor prognosis and limited treatment options require the use of new chemotherapeutic agents. We report the case of an eight year old boy with non metastatic alveolar rhabdomyosarcoma of the right forearm (Group 3, Stage III). After treatment failure of several...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , |
| التنسيق: | article |
| منشور في: |
2011
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/2257 http://dx.doi.org/10.2174/157488511795304912 http://www.ingentaconnect.com/content/ben/cdth/2011/00000006/00000002/art00003 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513457849630720 |
|---|---|
| author | Nasser, Soumana C. |
| author2 | Farah, Roula A. Sabbagh, Racha A. Dina, Pele B. Eid, Toufic A. |
| author2_role | author author author author |
| author_facet | Nasser, Soumana C. Farah, Roula A. Sabbagh, Racha A. Dina, Pele B. Eid, Toufic A. |
| author_role | author |
| dc.creator.none.fl_str_mv | Nasser, Soumana C. Farah, Roula A. Sabbagh, Racha A. Dina, Pele B. Eid, Toufic A. |
| dc.date.none.fl_str_mv | 2011-05-02 2015-10-06T08:59:01Z 2015-10-06T08:59:01Z 2015-10-06 |
| dc.identifier.none.fl_str_mv | 1574-8855 http://hdl.handle.net/10725/2257 http://dx.doi.org/10.2174/157488511795304912 A Farah, R., C Nasser, S., A Sabbagh, R., B Dina, P., & A Eid, T. (2011). Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma. Current Drug Therapy, 6(2), 97-99. http://www.ingentaconnect.com/content/ben/cdth/2011/00000006/00000002/art00003 |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Current Drug Therapy |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | Refractory soft tissue sarcomas carry a poor prognosis and limited treatment options require the use of new chemotherapeutic agents. We report the case of an eight year old boy with non metastatic alveolar rhabdomyosarcoma of the right forearm (Group 3, Stage III). After treatment failure of several chemotherapeutic regimens and progression of his disease, Trabectedin was administered at 1.3 mg/m2/dose intravenously over 24 hours for two cycles. The patient's quality of life improved as noted by a significant decrease in opiate requirements and ability to tolerate oral intake. The drug was well tolerated with the exception of transient neutropenia. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_df084a2efe079b994217a03faf9a20ce |
| identifier_str_mv | 1574-8855 A Farah, R., C Nasser, S., A Sabbagh, R., B Dina, P., & A Eid, T. (2011). Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma. Current Drug Therapy, 6(2), 97-99. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/2257 |
| publishDate | 2011 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | Palliative Tumor Control by Trabectedin in Pediatric Advanced SarcomaNasser, Soumana C.Farah, Roula A.Sabbagh, Racha A.Dina, Pele B.Eid, Toufic A.Refractory soft tissue sarcomas carry a poor prognosis and limited treatment options require the use of new chemotherapeutic agents. We report the case of an eight year old boy with non metastatic alveolar rhabdomyosarcoma of the right forearm (Group 3, Stage III). After treatment failure of several chemotherapeutic regimens and progression of his disease, Trabectedin was administered at 1.3 mg/m2/dose intravenously over 24 hours for two cycles. The patient's quality of life improved as noted by a significant decrease in opiate requirements and ability to tolerate oral intake. The drug was well tolerated with the exception of transient neutropenia.PublishedN/A2015-10-06T08:59:01Z2015-10-06T08:59:01Z2011-05-022015-10-06Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1574-8855http://hdl.handle.net/10725/2257http://dx.doi.org/10.2174/157488511795304912A Farah, R., C Nasser, S., A Sabbagh, R., B Dina, P., & A Eid, T. (2011). Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma. Current Drug Therapy, 6(2), 97-99.http://www.ingentaconnect.com/content/ben/cdth/2011/00000006/00000002/art00003enCurrent Drug Therapyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/22572016-08-22T08:14:59Z |
| spellingShingle | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma Nasser, Soumana C. |
| status_str | publishedVersion |
| title | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| title_full | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| title_fullStr | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| title_full_unstemmed | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| title_short | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| title_sort | Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma |
| url | http://hdl.handle.net/10725/2257 http://dx.doi.org/10.2174/157488511795304912 http://www.ingentaconnect.com/content/ben/cdth/2011/00000006/00000002/art00003 |